Recognizing Lung Cancer Awareness Month
The Barbara Ann Karmanos Cancer Institute diligently acknowledges November as Lung Cancer Awareness Month, joining forces with cancer centers and organizations across the nation. This month serves as a vital reminder about the prevalence of lung cancer, the second most commonly diagnosed cancer in both men and women.
Lung Cancer: Key Statistics
According to current statistics, approximately 226,650 new lung cancer cases will be diagnosed this year. The odds of a man developing lung cancer at some point in his life are about 1 in 17, while a woman’s odds stand at about 1 in 18.
Understanding the Impact of Lung Cancer
Lung cancer remains the leading cause of cancer-related deaths for both genders. Each year, it claims more lives than colon, breast, and prostate cancers combined. A staggering 80 to 90 percent of deaths attributed to lung cancer are believed to result from smoking.
Importance of Early Detection
"In the early stages of lung cancer, symptoms might be virtually non-existent. Hence, early detection is pivotal for improving survival rates associated with this severe disease," states Khalil Choucair, M.D., a medical oncologist at Karmanos. He emphasizes the importance of screenings, especially for high-risk individuals, as they significantly increase the chances of survival and effective treatment.
Symptoms and Risk Factors for Lung Cancer
When it comes to symptoms of lung cancer, individuals may experience persistent coughing, coughing up blood, chest pain, damage to appetite, unexplained weight loss, fatigue, shortness of breath, wheezing, or recurrent respiratory infections. As the disease progresses, it may lead to bone pain, jaundice, or swollen lymph nodes. The cancer can even advance to the brain, triggering changes in the nervous system such as dizziness, balance issues, weakness, numbness, headaches, or seizures.
Smoking is recognized as the primary risk factor, with other contributors such as second-hand smoke, radon exposure, and various carcinogens. Additionally, some risk factors are beyond control like air pollution and family history.
Resources Available for Smoking Cessation
Smoking not only elevates the risk of developing lung cancer but also associates with nearly every type of cancer. Its harmful effects extend to bystanders, including children, as second-hand smoke is linked to numerous health complications, encompassing cancer, lung diseases, asthma, ear infections, and heightened susceptibility to illnesses in non-smokers. People are encouraged to seek assistance and utilize available resources for quitting smoking, as support can significantly increase chances of success in quitting.
Lung Cancer Screening Procedures
The lung cancer screening process consists of multiple steps, beginning with a consultation to evaluate individual needs and risks. Eligible candidates undergo low-dose CT scans, a more sensitive alternative to standard X-rays, making the detection of abnormalities much more effective.
Individuals aged between 50 and 80 who are current smokers or have quit within the past 15 years, with a history of at least 20 pack-years of smoking, should consider undergoing lung cancer screening. Medicare covers screenings for patients aged 50-77, and most commercial insurance providers cover it for those aged 55-80. Typically, there are no out-of-pocket expenses for low-dose CT lung screenings; however, patients should verify with their insurance provider and ensure their physician provides a referral.
In Dr. Choucair's words, "If you are a current or former smoker, I advise discussing with your primary care doctor about the option for a lung cancer screening referral. These screenings allow for earlier cancer detection, which translates into more treatment avenues and a heightened probability of recovery."
Lung Cancer Treatment at Karmanos
At Karmanos, patients diagnosed with lung cancer benefit from a multidisciplinary team dedicated to thoracic oncology. This group includes various experts such as surgeons, medical oncologists, radiation oncologists, radiologists, pulmonologists, pathologists, pharmacists, nutritionists, social workers, and genetic counselors. Together, they tailor a comprehensive treatment approach for each patient.
"Choosing Karmanos for lung cancer treatment means becoming part of a comprehensive care team, where each physician is committed to providing the highest quality care. Our specialists coordinate all aspects of your treatment journey to ensure that you and your family are informed of the best options available," Dr. Choucair further elaborated.
Karmanos' thoracic oncologists are national authorities in managing chest malignancies, with ongoing participation in developing new therapeutic agents for treating thoracic cancers. The institute also leads national and international clinical trials aimed at evaluating new treatment methodologies.
For more information regarding lung cancer screening and preventative care, reach out to Karmanos Cancer Institute or call 1-800-KARMANOS.
Frequently Asked Questions
What is Lung Cancer Awareness Month?
Lung Cancer Awareness Month is recognized in November to increase awareness about lung cancer and the importance of screenings.
How common is lung cancer among the population?
Approximately 226,650 new cases of lung cancer are expected to be diagnosed annually, making it a significant health concern.
What are the symptoms of lung cancer?
Symptoms can include persistent cough, chest pain, shortness of breath, fatigue, and weight loss among others.
Who is at risk for lung cancer?
Current and former smokers are the primary risk groups, along with those exposed to second-hand smoke or certain environmental factors.
What resources are available for quitting smoking?
Several resources exist, such as counseling and support programs, aimed at helping individuals quit smoking effectively.
